Overall rank by patents
#32,431
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, active 2018–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,).
The verdict
Metarail holds 8 US patents across 3 technology areas, rank #32,431 of 50,000 tracked assignees.
Metarail, Inc. has been granted 8 US utility patents between 2018 and 2021, placing Metarail, Inc. at rank #32,431 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,). As a US Corporation, Metarail, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Metarail sits between MEON Medical Solutions Gmbh & Co KG (8 patents, rank #32,427) and Micro-controle—spectra-physics (8 patents, rank #32,435) - the closest US assignees by grant volume. The composite Innovation Score of 23.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 2 in the 2015–2019 window, a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Metarail, Inc.'s 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Metarail, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MEON MEDICAL SOLUTIONS GMBH & CO KG
8 patents
MESNAC CO., LTD.
8 patents
MESSIKA GROUP
8 patents
META INTELLIGENCE LLC
8 patents
METIMEDI PHARMACEUTICALS CO., LTD.
8 patents
METTER TOLEDO (CHANGZHOU) SCALE & SYSTEM LTD.
8 patents
MEYN BEHEER B.V.
8 patents
MICRO-CONTROLE—SPECTRA-PHYSICS
8 patents
METARAIL, INC.
8 patents
What this shows Metarail holds 8 patents at rank #32,431, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,431 in granted patent volume.
Other assignees with the most granted patents in Metarail's primary technology class.
Metarail's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 88% higher than 12% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2020 | 4 | 50.0% |
| 2021 | 2 | 25.0% |
Top 3 of 3 technology areas
Overall rank by patents
#32,431
Across all tracked assignees
23.5 out of 100
How to use this portfolio
Metarail's 8 grants land it in the top 88% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.